Management ChangeApr 22, 2026, 04:07 PM
Amgen CTO David M. Reese to Retire, Responsibilities Redistributed
AI Summary
Amgen Inc. announced the retirement of David M. Reese, Executive Vice President and Chief Technology Officer, effective June 30, 2026. His responsibilities will be redistributed among James E. Bradner (EVP, Research and Development, AI and Data), Murdo Gordon (EVP, Amgen Global Markets and Policy), and Peter H. Griffith (EVP and CFO), effective June 1, 2026. This move aims to further integrate science, technology, and data, and align commercial, medical, and policy teams.
Key Highlights
- David M. Reese is retiring as Executive Vice President and Chief Technology Officer.
- His retirement is effective June 30, 2026.
- Responsibilities will be redistributed to James E. Bradner, Murdo Gordon, and Peter H. Griffith.
- The redistribution of responsibilities is effective June 1, 2026.
Price Impact
More from AMGN